908 Devices Inc.

908 Devices Inc. is a publicly traded company specializing in the development and manufacturing of purpose-built handheld and desktop devices for point-of-need chemical and biochemical analysis. Founded in 2012, the company is headquartered in Burlington, Massachusetts. Its mission is to simplify, smarten, and speed up chemical analysis, enabling users to take swift action in critical applications.

The company's product portfolio includes a range of analytical instruments such as the MX908, a handheld mass spectrometer for trace-level detection of narcotics, explosives, and hazardous materials; VipIR, a chemical analyzer combining FTIR and Raman spectroscopy; XplorIR, a handheld gas and vapor analyzer; and ProtectIR/ThreatID, FTIR-based bulk identification instruments. They also offer desktop solutions like Rebel, an analyzer for bioprocesses, and ZipChip, a microfluidic separation platform for mass spectrometry sample analysis. These devices serve diverse market segments including safety and security, public safety, hazmat, defense, forensics, life sciences research, bioprocessing, and industrial biotechnology, with a focus on government and law enforcement agencies.

Led by CEO and Co-founder Kevin J. Knopp, 908 Devices Inc. continues to innovate in the analytical technology space. Recent developments include the appointment of Kola Otitoju as Chief Business & Strategy Officer in April 2026 and the reporting of strong Q4 2025 financial results in March 2026, which included a positive adjusted EBITDA. The company also divested its desktop bioprocessing portfolio in April 2026 to enhance cash reserves and streamline operations. 908 Devices operates globally, with a presence across North America, Europe, the Middle East, Africa, and Asia Pacific.